Gevokizumab FDA Approval Status
FDA Approved: No
Generic name: gevokizumab
Company: XOMA Corporation
Treatment for: Uveitis
Gevokizumab is a potent monoclonal antibody in development for the treatment of non-infectious uveitis.
Development timeline for gevokizumab
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
